אונדנסטרון אינובמד 4 מג Ισραήλ - Εβραϊκά - Ministry of Health

אונדנסטרון אינובמד 4 מג

inovamed ltd - ondansetron as hydrochloride dihydrate - טבליות מצופות פילם - ondansetron as hydrochloride dihydrate 4 mg - ondansetron

אונדנסטרון אינובמד 8 מג Ισραήλ - Εβραϊκά - Ministry of Health

אונדנסטרון אינובמד 8 מג

inovamed ltd - ondansetron as hydrochloride dihydrate - טבליות מצופות פילם - ondansetron as hydrochloride dihydrate 8 mg - ondansetron

אמולסידרם Ισραήλ - Εβραϊκά - Ministry of Health

אמולסידרם

trupharm marketing 1985 ltd. - benzalkonium chloride 0.5 %w/v; isopropyl myristate 25 %w/v - emulsion - benzalkonium - for the treatment of dry skin conditions especially associated with eczema, ichtyosis or xeroderma. it permits rehydratation of the keratin.

רקויפ מודוטאב 2 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

רקויפ מודוטאב 2 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 2 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקוויפ מודוטאב 2 מג Ισραήλ - Εβραϊκά - Ministry of Health

רקוויפ מודוטאב 2 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 2 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקויפ מודוטאב 8 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

רקויפ מודוטאב 8 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 8 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקוויפ מודוטאב 8 מג Ισραήλ - Εβραϊκά - Ministry of Health

רקוויפ מודוטאב 8 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 8 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקויפ מודוטאב 4 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

רקויפ מודוטאב 4 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 4 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקוויפ מודוטאב 4 מג Ισραήλ - Εβραϊκά - Ministry of Health

רקוויפ מודוטאב 4 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 4 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

ניאוטיגאזון 25 מג Ισραήλ - Εβραϊκά - Ministry of Health

ניאוטיגאזון 25 מג

abic marketing ltd, israel - acitretin - קפסולות - acitretin 25 mg - acitretin - acitretin - severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.